I agree that this site is using cookies. You can find further informations here.
X
Mulero‐Sánchez, Antonio
14  results:
Search for persons X
?
1

Rational combination of SHP2 and mTOR inhibition for the tr..:

Mulero‐Sánchez, Antonio ; Ramirez, Christel F. A. ; du Chatinier, Aimée...
Molecular Oncology.  17 (2023)  6 - p. 964-980 , 2023
Link: https://doi.org/10.1002/..
 
?
2

Paradoxical Activation of Oncogenic Signaling as a Cancer T..:

Dias, Matheus Henrique ; Friskes, Anoek ; Wang, Siying...
Cancer Discovery.  14 (2024)  7 - p. 1276-1301 , 2024
Link: https://doi.org/10.1158/..
 
?
3

Extensive preclinical validation of combined RMC-4550 and L..:

Frank, Katrin J. ; Mulero-Sánchez, Antonio ; Berninger, Alexandra...
Cell Reports Medicine.  3 (2022)  11 - p. 100815 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Genetic and compound screens uncover factors modulating can..:

Pogacar, Ziva ; Groot, Kelvin ; Jochems, Fleur...
Life Science Alliance.  5 (2022)  9 - p. e202101348 , 2022
Link: https://doi.org/10.26508..
 
?
5

Importance of genetic screens in precision oncology:

Mulero-Sánchez, Antonio ; Pogacar, Ziva ; Vecchione, Loredana
ESMO Open.  4 (2019)  3 - p. e000505 , 2019
Link: https://doi.org/10.1136/..
 
?
6

Rational combination of SHP2 and mTOR inhibition for the tr..:

Mulero‐Sánchez, Antonio ; Ramirez, Christel F. A ; du Chatinier, Aimée...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257427/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
7

All roads lead to SHP2:

Mulero-Sánchez, Antonio
https://dspace.library.uu.nl/handle/1874/430725.  , 2023
Link: https://dspace.library.u..
 
?
8

Rational combination of SHP2 and mTOR inhibition for the tr..:

Antonio Mulero‐Sánchez ; Christel F. A. Ramirez ; Aimée duChatinier...
https://doi.org/10.1002/1878-0261.13377.  , 2023
Link: https://doi.org/10.1002/..
 
?
9

Extensive preclinical validation of combined RMC-4550 and L..:

Frank, Katrin J ; Mulero-Sánchez, Antonio ; Berninger, Alexandra...
http://dx.doi.org/10.1016/j.xcrm.2022.100815.  , 2022
Link: http://hdl.handle.net/10..
 
?
10

Extensive preclinical validation of combined RMC-4550 and L..:

Frank, Katrin J ; Mulero-Sánchez, Antonio ; Berninger, Alexandra...
https://freidok.uni-freiburg.de/data/231457.  , 2022
Link: https://freidok.uni-frei..
 
?
11

Genetic and compound screens uncover factors modulating can..:

Pogacar, Ziva ; Groot, Kelvin ; Jochems, Fleur...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095732/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
12

Extensive preclinical validation of combined RMC-4550 and L..:

Frank, Katrin J ; Mulero-Sánchez, Antonio ; Berninger, Alexandra...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729824/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
13

Importance of genetic screens in precision oncology:

Antonio Mulero-Sánchez ; Ziva Pogacar ; Loredana Vecchione
https://esmoopen.bmj.com/content/4/3/e000505.full.  , 2019
Link: https://doi.org/10.1136/..
 
?
14

SHP2 is required for growth of KRAS-mutant non-small-cell l..:

Mainardi, Sara ; Mulero-Sánchez, Antonio ; Prahallad, Anirudh...
info:eu-repo/semantics/altIdentifier/pmid/29808006.  , 2018
Link: http://hdl.handle.net/23..
 
1-14